Board Members
Eng. Fahad AlJarbou
Chairman of Board of Directors
Obaid Al Rasheed
Deputy Chairman of the Board
Eng. Thamer Al Muhid
Member
Fawaz Al-Fawaz
Member
Mohammed Bin Daoud
Member
Eng. Fahad AlJarbou
Chairman of Board of Directors
Obaid Al Rasheed
Deputy Chairman of the Board
Eng. Thamer Al Muhid
Member
Fawaz Al-Fawaz
Member
Mohammed Bin Daoud
Member
CEO Message
Dimitri Livadas,
"At Sihavita, our commitment to enhancing health and quality of life is deeply intertwined with our dedication to sustainability and fostering a 'Vibrant Society.'
As we align our efforts with Saudi Arabia’s Vision 2030, we are deeply committed to supporting the Kingdom’s pillars and objectives through our contributions in ensuring drug security, localizing pharmaceutical technology, and diversifying the economy.
We aim to propel prosperity through innovative healthcare solutions, aiming to transform local and global health landscapes. By participating in local and regional initiatives to boost pharmaceutical distribution and logistical solutions and manufacturing capabilities to global standards and securing strategic agreements to enhance drug security, Sihavita is playing a critical role in meeting the healthcare needs of today and tomorrow.
We see every challenge as a gateway to leadership in sustainability, and every innovation as a stride toward a more vibrant and prosperous future."
Pharma Lead Team
Emad Ibrahim
CFO Pharma
Chadi Asaad
VP Of Strategy &
Operations
Khaled Almadani
VP Commercial
Basil Alshaalan
GM Regulatory &
Medical Affairs
Ziad Amayreh
GM Plant
Amer Alenazi
GM Supply Chain
Moshrif Al-Amri
GM Compliance
Muhammad Ghazali
Director PMO